Welcome to our dedicated page for Aptargroup SEC filings (Ticker: ATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AptarGroup, Inc. (ATR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New York Stock Exchange-listed issuer, Aptar files current reports, annual and quarterly reports and other documents that explain its financial condition, capital structure and material events affecting the business.
Investors can review Form 8-K filings for announcements such as quarterly results and financing transactions. For example, a Form 8-K dated November 20, 2025 describes an underwritten public offering of 4.750% senior notes due 2031, including key terms of the notes, redemption provisions and related underwriting agreements. Other 8-K filings reference the release of quarterly earnings information for periods such as the quarter ended September 30, 2025.
Alongside current reports, users can consult Aptar’s periodic filings, including Form 10-K annual reports and Form 10-Q quarterly reports, which typically provide segment information for Aptar Pharma, Aptar Beauty and Aptar Closures, as well as discussions of risk factors and liquidity. Filings related to debt instruments, indentures and other agreements give additional insight into the company’s capital structure.
Stock Titan enhances these documents with AI-powered tools that summarize key points, highlight significant terms and help explain complex sections in plain language. Users can quickly identify items such as new debt offerings, results of operations disclosures and other material events, while retaining the ability to read the full original filings. This page is a starting point for analyzing how Aptar reports its performance, governance and financing activities to regulators and the market.
AptarGroup, Inc. plans to issue new unsecured senior notes to refinance existing borrowings. The notes rank equally with Aptar’s other unsecured debt, are structurally junior to subsidiary liabilities, and include optional redemption and a 101% repurchase feature if a change of control and ratings downgrade occur. Net proceeds are expected to repay all $125.0 million 3.61% notes due 2025, all $125.0 million 3.61% notes due 2026, and outstanding U.S. dollar borrowings under the revolving credit facility, with any remainder for general corporate purposes. Aptar reports net sales of $2,814.4 million and net income attributable to Aptar of $318.4 million for the nine months ended September 30, 2025, with Net Debt of $935.6 million and Net Debt to Net Capital of 25.1% as of that date.
AptarGroup (ATR) reported an initial Form 3 for Irene Hudson, EVP and Chief Legal Officer. She directly owns 798 shares of common stock and holds stock options for 842 shares at $111.38 expiring 03/15/2033, 1,189 shares at $141 expiring 03/15/2034, and 1,030 shares at $147.84 expiring 03/17/2035. Each option vests in three equal installments beginning on the first anniversary of the grant date.
AptarGroup (ATR) reported higher Q3 2025 revenue and earnings. Net sales rose to $961.1 million from $909.3 million, led by Aptar Pharma ($445.4 million), Beauty ($327.8 million) and Closures ($188.0 million). Operating income was $136.9 million versus $138.3 million a year ago. Other income benefited from a $26.5 million gain from remeasurement of an equity method investment.
Profitability improved year over year. Net income attributable to AptarGroup was $127.9 million (diluted EPS $1.92) versus $100.0 million ($1.48). For nine months, sales reached $2.81 billion with net income of $318.4 million (EPS $4.75) versus $2.73 billion and $273.6 million (EPS $4.05).
Balance sheet and cash flow remained solid. Cash and equivalents were $257.1 million; total assets were $5.10 billion. Net cash provided by operations was $386.3 million. The company used cash for capital expenditures ($183.6 million), treasury stock purchases ($190.0 million) and dividends ($89.3 million). Revolving credit borrowings totaled $187.0 million and €130.0 million under the amended facility. Leverage and coverage remained well within covenants at 1.22x and 17.02x, respectively. Shares outstanding were 65,619,154 as of October 27, 2025.
AptarGroup, Inc. (ATR) furnished an 8-K announcing that it released certain information related to its results of operations for the quarter ended September 30, 2025. The company provided a press release as Exhibit 99.1.
The company stated the furnished information in Item 2.02 and Exhibit 99.1 is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated into other filings unless specifically referenced. AptarGroup’s common stock trades on the NYSE under the symbol ATR.
AptarGroup (ATR) insider sale by Segment President Touya Gael. The Form 4 reports that on 09/11/2025 Mr. Gael sold a total of 2,500 shares of AptarGroup common stock in two sets of transactions: 2,110 shares at a weighted-average price of $136.1325 and 390 shares at a weighted-average price of $136.0467. Following those reported sales, the filing shows beneficial ownership of 31,853 shares after the first sale and 31,463 shares after the second sale. The filing was signed by an attorney-in-fact on 09/12/2025 and includes explanations that the reported prices are weighted averages across multiple trades.
AptarGroup, Inc. (ATR) filed a Form 144 notifying the proposed sale of 2,500 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $340,297.75 and an approximate sale date of 09/11/2025. The filing reports total outstanding shares of 65,880,522, which gives context to the size of the proposed sale relative to the company's share count.
The securities listed were acquired in 2021 through restricted stock vesting under a registered plan: 603 shares on 03/25/2021, 1,126 shares on 02/28/2021 and 771 shares on 03/23/2021, each noted as payment for services rendered. The filer indicates no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Insider sale reported: Shiela Vinczeller, Chief Human Resources Officer of AptarGroup, Inc. (ATR), reported selling 1,167 shares of AptarGroup common stock on 09/05/2025 at a weighted average price of $137.9661 per share. Following the sale, the filing shows she beneficially owns 25,134 shares, held directly.
The Form 4 was signed by an attorney-in-fact on 09/08/2025 and includes an explanation that the reported price is a weighted average for multiple transactions executed between $137.85 and $138.09. The filing is a routine Section 16 disclosure of a non-derivative disposition by an officer.
AptarGroup, Inc. (ATR) filed a Form 144 reporting a proposed sale of 1,167 common shares. The sale is to be handled by Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $161,006.44 and an approximate sale date of 09/05/2025. The shares were acquired on 05/02/2025 through restricted stock vesting under a registered plan and were issued by the issuer as payment for services rendered on 05/02/2025. The filer reports no securities sold in the past three months. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.